Pfizer

Pfizer Has Potential To Grow Despite Decreasing Sales

Pfizer Has Potential To Grow Despite Decreasing Sales

Seeking Alpha

Pfizer

Merck, Lilly, Pfizer share top billing in $1B doc-payments list

Merck, Lilly, Pfizer share top billing in $1B doc-payments list

Fierce Pharma

J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer

J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer

Forbes

Pfizer takes its shot at a vaccine for evasive superbug

Pfizer takes its shot at a vaccine for evasive superbug

Yahoo/Reuters

4 Big Drug Companies With Big Juicy Yields

4 Big Drug Companies With Big Juicy Yields

Motley Fool

Pfizer to spin off Zoetis stake to shareholders

Pfizer to spin off Zoetis stake to shareholders

Yahoo/Reuters

Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl

Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl

NASDAQ.com

A New Drug Sales Model

A New Drug Sales Model

Motley Fool

Pfizer halts study of lymphoma drug unlikely to help survival

Pfizer halts study of lymphoma drug unlikely to help survival

Reuters

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Motley Fool